Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Current Deferred Tax Assets: 2020-2022

Historic Current Deferred Tax Assets for Universe Pharmaceuticals (UPC) over the last 3 years, with Sep 2022 value amounting to $702.9 billion.

  • Universe Pharmaceuticals' Current Deferred Tax Assets rose 9587190.43% to $728.1 billion in Q1 2023 from the same period last year, while for Mar 2023 it was $728.1 billion, marking a year-over-year increase of 9587190.43%. This contributed to the annual value of $702.9 billion for FY2022, which is 9381373.30% up from last year.
  • Universe Pharmaceuticals' Current Deferred Tax Assets amounted to $702.9 billion in FY2022, which was up 9,381,373.30% from $7.5 million recorded in FY2021.
  • Over the past 5 years, Universe Pharmaceuticals' Current Deferred Tax Assets peaked at $702.9 billion during FY2022, and registered a low of $7.5 million during FY2021.
  • In the last 3 years, Universe Pharmaceuticals' Current Deferred Tax Assets had a median value of $443.7 billion in 2020 and averaged $382.2 billion.
  • Its Current Deferred Tax Assets has fluctuated over the past 5 years, first slumped by 100.00% in 2021, then surged by 9,381,373.30% in 2022.
  • Yearly analysis of 3 years shows Universe Pharmaceuticals' Current Deferred Tax Assets stood at $443.7 billion in 2020, then slumped by 100.00% to $7.5 million in 2021, then spiked by 9,381,373.30% to $702.9 billion in 2022.